Photo from Amanda Nerstad/X
Jul 11, 2024, 04:40
Amanda Nerstad: This is hope
Amanda Nerstad, Lung cancer survivor and advocate, shared on X:
“This is hope. Patient #2 in the Peptide vaccine ALK plus NSCLC clinical trial!
We are hopeful this groundbreaking vaccine will turn this terminal disease into a chronic one. I believe in my doctor as much as he believes in me.”
Yvonne Diaz, Co-founder at Oncogene Cancer Research, replied:
“This is what hope and research look like. Thank you Amanda Nerstad, for supporting this research by Dr Vincent Lam into an ALK+ cancer vaccine.
Appreciate all the patients who participate in clinical trials improving our survival and care.”
Source: Amanda Nerstad/X and Yvonne Diaz/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33